Home > Financial Ratios > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 23.475.994.318.18

What is the latest EV/Core EBITDA ratio of SENORES PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SENORES PHARMACEUTICALS is 23.47 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202523.47
Mar20245.99
Mar20234.31
Mar20228.18

How is EV/Core EBITDA of SENORES PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 23.47
291.82
Mar2024 5.99
38.98
Mar2023 4.31
-47.31
Mar2022 8.18 -

Other Financial Ratios of SENORES PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SENORES PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS ₹6,982.5 Cr -2.1% 8.5% 124.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,090.0 Cr 1% -2.7% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,976.0 Cr 0.7% 17.1% 40.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,639.0 Cr -0.3% -3.7% 37.9% Stock Analytics
CIPLA ₹115,216.0 Cr -0.3% 2.3% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr -1.4% 0.7% -6.2% Stock Analytics


SENORES PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS

-2.1%

8.5%

124.6%

SENSEX

-0.6%

1%

-3.7%


You may also like the below Video Courses